Biodesix announces Clin-TOF successfully integrated into VeriStrat Workflow

Thursday, January 26, 2017

BOULDER, Colo.--(BUSINESS WIRE)--Study results presented today demonstrate the feasibility of running the VeriStrat® test on Bioyong’s Clin-TOF platform, and provide a basis for validating and deploying a version of the VeriStrat® test in Greater China. The data were presented in a poster at the ninth annual conference of the Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL) in Palm Springs, California. 

Colorado BioScience Association welcomes nationally recognized thought leaders to address state’s medical device industry

Friday, January 20, 2017

DENVER – Colorado BioScience Association (CBSA) highlights how changes in federal policy, major shifts in healthcare will impact the state’s thriving medical device industry as part of the annual CBSA Medical Device Symposium. Medical device sector policy discussions will cover the opportunities presented by proposed regulatory relief, corporate tax reform and the possible full repeal of the medical device excise tax under the new administration. 

ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial

Wednesday, January 18, 2017

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that the 150thpatient has been randomized into GENETIC-AF, a seamless Phase 2B/3 clinical trial evaluating GencaroTM (bucindolol hydrochloride) as a potential treatment for atrial fibrillation (AF). 

NCH in Metro Chicago Joins CereScan Family to Help Patients with Head and Chronic Brain Injuries

Wednesday, January 18, 2017

CereScan® has increased its functional brain imaging diagnostics network with the addition of Northwest Community Healthcare (NCH) in Arlington Heights. Patients in the Midwest region who are suffering from lingering head and brain injuries may now use the nation’s leading provider of statistically measured brain diagnostics to understand the biological basis of their symptoms for a more direct path to treatment and recovery. 

Viewpoint: Repeal the medical device tax to improve patient health and grow R&D

Friday, January 13, 2017

Christopher Banas
CEO, BiO2 Medical
Special to the Business Journal 

Boomtown Accelerator forges relationship with Colorado BioScience Association

Wednesday, January 11, 2017

BOULDER, Colo — Jan. 10, 2017 — Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited to announce that they have established a relationship with the Colorado BioScience Association (CBSA). 

Symbios Announces National Science Foundation SBIR Phase IIB Award to Commercialize Plasma Oxidation Technology

Wednesday, January 11, 2017

Fort Collins, Colorado, January 11, 2017 - Symbios Technologies, Inc., a world-leading developer of dynamic aqueous plasma technology platforms, announced today that the National Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) Phase IIB supplement for $500,000. The funds will be used to commercialize the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer deployment to treat industrial process and wastewater. 

AVEX LLC Raises $7.6 Million In Series A Financing Round For 1st Quarter Launch Of Footbeat

Tuesday, January 10, 2017

Grand Junction, CO - January 10, 2017AVEX LLC, an innovative Colorado-based medical device company, today announced the securing of $7.6 million in Series A financing that will fuel the Q1 2017 launch of Footbeat, the only wearable technology that improves health and athletic performance by increasing circulation through precise, cyclic pressure applied to the arch of the foot. 

Biodesix® and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat® Test in Greater China

Monday, January 09, 2017

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and commercialize a version of Biodesix’s VeriStrat® proteomic blood test, a precision medicine diagnostic for patients with non-small cell lung cancer (NSCLC), for clinical use in Greater China, with potential expansion into other Asia-Pacific countries. 

Gov. Hickenlooper announces "Call for Innovation" to help underserved Colorado Youth

Monday, January 09, 2017

Gov. John Hickenlooper today announced the “Colorado Call for Innovation,” soliciting innovative approaches from nonprofits, local governments and service providers to improve outcomes for Colorado underserved youth and their families.